-
Hager Bioscience, LLC
HAGER BIOSCIENCES, LLC is a preclinical-stage drug discovery company based on innovative medicinal chemistry capabilities that provides sought-after therapeutic leads for unmet medical needs. Hager’s discovery fragment pharmacophore platform, FragPhore®, provides a competitive advantage for the efficient and rapid optimization of a drug candidate’s medicinal chemistry, improvement in pharmaceutical properties, and enhancement of intellectual property. Continue Reading…
-
Azevan Pharmaceuticals, LLC
AZEVAN PHARMACEUTICALS LLC develops pharmaceuticals for the treatment of central nervous system (CNS) disorders. Its focus has been on stress-related affective illness resulting in anxiety and depression, CNS disorders causing aggression, and female health issues. Its lead compound, SRX246, is in a Phase II clinical trial for treatment of Intermittent Explosive Disorder and other mood Continue Reading…